Fragonomics: fragment-based drug discovery
- PMID: 15925537
- DOI: 10.1016/j.cbpa.2005.05.002
Fragonomics: fragment-based drug discovery
Abstract
The use of smaller molecules (fragments) in the drug discovery process has led to success in delivering novel leads for many different targets. This process is a highly integrated process, starting from library design to screening and medicinal chemistry. An overview of this process is presented with particular emphasis placed on the NMR aspect of screening.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
